comparemela.com

Latest Breaking News On - ஆக்ஸ்ஃபர்ட்‌ஶைர் உள்ளூர் நிறுவன கூட்டு - Page 1 : comparemela.com

Antibodies Developer locates to Oxford Trust s Wood Centre Labmate Online

Jun 29 2021 DJS Antibodies has announced its move into over 2,000 sqft of newly converted class II laboratory and office space at The Oxford Trust’s Wood Centre for Innovation, the second biotech to join alongside recent occupant Samsara Therapeutics. Founded in 2015 by David Llewellyn and Joe Illingworth, who met at the University of Oxford’s Jenner Institute, DJS is working on therapeutics to treat critical inflammatory diseases that account for more than 50% of deaths worldwide. The lead programme of its HEPTAD antibody discovery platform targets a validated GPCR (G protein-coupled receptor) for the treatment of Diabetic Kidney Disease, a long-term condition that causes the irreversible loss of kidney function.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.